BeStock  
Stocks › ELVN

Enliven Therapeutics ELVN

US equityMarket cap rank #2407
$45.47 −$1.50 (-3.19%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $45.20 -0.59%
Open$46.94
Prev close$46.97
Day range$45.23 – $46.94
Volume821.5K
Market cap$3.33B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts14
Average target$73.67+62.0% vs. price
  • Buy 100%
Low $65.00Now $45.47Avg $73.67High $82.00

Recent rating changes

The last 20 actions on file set price targets from $65.00 to $82.00, averaging $73.71.

DateFirmRatingTarget
5 Oct 2026 Morgan Stanley BUY $70.00
2 Oct 2026 Morgan Stanley BUY $70.00
1 Oct 2026 J.P. Morgan BUY $75.00
22 Aug 2026 William Blair BUY –
18 Aug 2026 William Blair BUY –
18 Aug 2026 Barclays BUY $78.00
17 Aug 2026 Mizuho Securities BUY $73.00
13 Aug 2026 Stifel BUY $82.00
8 Aug 2026 LifeSci Capital BUY $70.00
7 Aug 2026 LifeSci Capital BUY $70.00
6 Aug 2026 JonesTrading BUY $70.00
6 Aug 2026 Baird BUY $75.00
6 Aug 2026 Clear Street BUY $68.00
6 Aug 2026 Stifel BUY $82.00
5 Aug 2026 TD Cowen BUY –
5 Aug 2026 Goldman Sachs BUY $80.00
5 Aug 2026 Guggenheim BUY $78.00
20 Jul 2026 Goldman Sachs BUY $67.00
9 Jul 2026 H.C. Wainwright BUY $65.00
1 Jul 2026 Stifel BUY $80.00

Discussion

No comments yet — be the first to weigh in on ELVN.

Leave a comment

Scroll to Top